MANKIND PHARMA
|
The Current P/E Ratio of MANKIND PHARMA is 43.91.
Share Price | ₹2,111.6 | May 18,2024 |
Market Cap | ₹84,588.7 Cr | |
Earnings-TTM | ₹1,926.6 Cr | TTM-Consolidated Results |
Price/Earnings | 43.91x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of MANKIND PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹84,588.7 Cr] as on May 18,2024
(/) Earnings [ ₹1,926.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 43.91x ]
Thus, for MANKIND PHARMA , the investors are currently willing to pay 43.91 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MANKIND PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MANKIND PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of MANKIND PHARMA
PE Ratio Performance Analysis for MANKIND PHARMA
- MANKIND PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.00x.
- MANKIND PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/e ratio peaked in Mar2023 at 0x.
- MANKIND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does MANKIND PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
MANKIND PHARMA | 1,926.55 | 43.91 | 84,588.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.82 | 367,290.0 |
CIPLA LTD | 4,155.31 | 27.28 | 113,357.0 |
DR REDDYS LABORATORIES LTD | 5,563.20 | 17.44 | 97,001.5 |
ZYDUS LIFESCIENCES LTD | 3,831.40 | 29.01 | 111,134.0 |
DIVIS LABORATORIES LTD | 1,382.97 | 75.37 | 104,235.0 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 61.28 | 91,556.3 |
LUPIN LTD | 1,935.57 | 39.09 | 75,652.2 |
AUROBINDO PHARMA LTD | 2,777.89 | 25.37 | 70,467.9 |
ABBOTT INDIA LTD | 1,201.22 | 47.13 | 56,616.0 |
ALKEM LABORATORIES LTD | 1,574.66 | 41.30 | 65,029.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MANKIND PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.44x |
Max industry PE | 75.37x |
Median industry PE | 40.82x |
Average industry PE | 40.73x |
You may also like the below Video Courses